ATLnsider
10 minutes ago
I agree ilovetech, as I indicated in my previous post below, it would be an interesting comparison of safety and efficacy, to compare the current UCLA Spore combination trial to a trial that replaces Keytruda (Pembrolizumab) with intravenous vitamin C.
The combination of DCVax-L alon